282 related articles for article (PubMed ID: 36813793)
1. Topical phage therapy in a mouse model of Cutibacterium acnes-induced acne-like lesions.
Rimon A; Rakov C; Lerer V; Sheffer-Levi S; Oren SA; Shlomov T; Shasha L; Lubin R; Zubeidat K; Jaber N; Mujahed M; Wilensky A; Coppenhagen-Glazer S; Molho-Pessach V; Hazan R
Nat Commun; 2023 Feb; 14(1):1005. PubMed ID: 36813793
[TBL] [Abstract][Full Text] [Related]
2. The immunomodulatory potential of phage therapy to treat acne: a review on bacterial lysis and immunomodulation.
Farfán J; Gonzalez JM; Vives M
PeerJ; 2022; 10():e13553. PubMed ID: 35910763
[TBL] [Abstract][Full Text] [Related]
3. Application of bacteriophage φPaP11-13 attenuates rat
Liu Y; Zhen N; Liao D; Niu J; Liu R; Li Z; Lei Z; Yang Z
Microbiol Spectr; 2024 Feb; 12(2):e0283823. PubMed ID: 38197658
[TBL] [Abstract][Full Text] [Related]
4. Therapeutic Effect of a Newly Isolated Lytic Bacteriophage against Multi-Drug-Resistant
Lam HYP; Lai MJ; Chen TY; Wu WJ; Peng SY; Chang KC
Int J Mol Sci; 2021 Jun; 22(13):. PubMed ID: 34209998
[TBL] [Abstract][Full Text] [Related]
5. Antibiotic resistant Cutibacterium acnes among acne patients in Jordan: a cross sectional study.
Alkhawaja E; Hammadi S; Abdelmalek M; Mahasneh N; Alkhawaja B; Abdelmalek SM
BMC Dermatol; 2020 Nov; 20(1):17. PubMed ID: 33203374
[TBL] [Abstract][Full Text] [Related]
6. Efficacy and Safety of VB-1953 Topical Gel in Non-Responder Acne Patients with Clindamycin-Resistant Cutibacterium acnes.
Batra R; Sadhasivam S; Saini S; Gupta S; Bisen RKS; Sinha M; Ghosh S; Jain S
Drugs R D; 2020 Jun; 20(2):95-104. PubMed ID: 32222937
[TBL] [Abstract][Full Text] [Related]
7. Antibiotics and Antimicrobial Resistance in Acne: Epidemiological Trends and Clinical Practice Considerations.
Dessinioti C; Katsambas A
Yale J Biol Med; 2022 Dec; 95(4):429-443. PubMed ID: 36568833
[TBL] [Abstract][Full Text] [Related]
8. Characterization of the newly isolated phage Y3Z against multi-drug resistant Cutibacterium acnes.
Xuan G; Wang Y; Wang Y; Lin H; Wang C; Wang J
Microb Pathog; 2023 Jul; 180():106111. PubMed ID: 37084823
[TBL] [Abstract][Full Text] [Related]
9. Therapeutic Efficacy of Sesquiterpene Farnesol in Treatment of
Wu GX; Wang YW; Wu CS; Lin YH; Hung CH; Huang HH; Kuo SM
Molecules; 2021 Sep; 26(18):. PubMed ID: 34577195
[TBL] [Abstract][Full Text] [Related]
10. Cutibacterium acnes: Much ado about maybe nothing much.
van Steensel MAM; Goh BC
Exp Dermatol; 2021 Oct; 30(10):1471-1476. PubMed ID: 34009698
[TBL] [Abstract][Full Text] [Related]
11. Antibiotic resistance in the topical treatment of acne vulgaris.
Leyden JJ
Cutis; 2004 Jun; 73(6 Suppl):6-10. PubMed ID: 15228128
[TBL] [Abstract][Full Text] [Related]
12. Antibiotic Susceptibility of Cutibacterium acnes Strains Isolated from Israeli Acne Patients.
Sheffer-Levi S; Rimon A; Lerer V; Shlomov T; Coppenhagen-Glazer S; Rakov C; Zeiter T; Nir-Paz R; Hazan R; Molho-Pessach V
Acta Derm Venereol; 2020 Oct; 100(17):adv00295. PubMed ID: 33021324
[TBL] [Abstract][Full Text] [Related]
13. In vitro Antimicrobial Activity of Acne Drugs Against Skin-Associated Bacteria.
Blaskovich MAT; Elliott AG; Kavanagh AM; Ramu S; Cooper MA
Sci Rep; 2019 Oct; 9(1):14658. PubMed ID: 31601845
[TBL] [Abstract][Full Text] [Related]
14. Propionibacterium acnes and antimicrobial resistance in acne.
Dessinioti C; Katsambas A
Clin Dermatol; 2017; 35(2):163-167. PubMed ID: 28274353
[TBL] [Abstract][Full Text] [Related]
15. [Phylotyping and Determining the Antimicrobial Susceptibility of Cutibacterium acnes Isolated from Patients with Acne Vulgaris].
Özel Kaya N; Usta İ; Demirçay ZÖ; Ülger Toprak N
Mikrobiyol Bul; 2021 Oct; 55(4):465-479. PubMed ID: 34666649
[TBL] [Abstract][Full Text] [Related]
16. Development of a topical bacteriophage gel targeting
Golembo M; Puttagunta S; Rappo U; Weinstock E; Engelstein R; Gahali-Sass I; Moses A; Kario E; Ben-Dor Cohen E; Nicenboim J; Ben David H; Sudakov K; Cohen A; Bassan M; Zak NB
Skin Health Dis; 2022 Jun; 2(2):e93. PubMed ID: 35677920
[TBL] [Abstract][Full Text] [Related]
17. Propionibacterium (Cutibacterium) acnes Bacteriophage Therapy in Acne: Current Evidence and Future Perspectives.
Castillo DE; Nanda S; Keri JE
Dermatol Ther (Heidelb); 2019 Mar; 9(1):19-31. PubMed ID: 30539425
[TBL] [Abstract][Full Text] [Related]
18. INDIVIDUAL ARTICLE: Antibiotic Stewardship in Acne: 2023 Update.
Issa NT; Kircik LH
J Drugs Dermatol; 2024 Feb; 23(2):SF37896s4-SF378969s10. PubMed ID: 38306149
[TBL] [Abstract][Full Text] [Related]
19. Acne and Propionibacterium acnes.
Bojar RA; Holland KT
Clin Dermatol; 2004; 22(5):375-9. PubMed ID: 15556721
[TBL] [Abstract][Full Text] [Related]
20.
Bronnec V; Eilers H; Jahns AC; Omer H; Alexeyev OA
Front Cell Infect Microbiol; 2021; 11():809792. PubMed ID: 35155271
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
